Thoratec Hit With Shareholder Suit Over Device Recall, Study

Law360, Los Angeles (January 24, 2014, 6:29 PM EST) -- An investor in medical device company Thoratec Corp. filed in California federal court a putative shareholder class action on Friday, claiming the company did not tell investors that its heart devices posed a high risk for blood clots and that stock prices tanked after a product recall and a negative study.

Plaintiff Bradley Cooper claims Thoratec failed to disclose in regulatory filings that its HeartMate II Left Ventricular Assist Device had a risk for fatal pump thrombosis. Cooper claims he bought 230 shares of the company...
To view the full article, register now.




Case Information

Case Title

Cooper v. Thoratec Corporation et al

Case Number



California Northern

Nature of Suit


Date Filed

January 24, 2014

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.